LTR Pharma jumps on first US sales of erectile dysfunction nasal spray ROXUS
Join our daily newsletter At The Bell to receive exclusive market insights LTR Pharma (ASX:LTP), best known for creating nasal-spray-based viagra alternatives, jumped +10% on Tuesday after fillings the first prescriptions for its ROXUS product in the US. …